INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$2.9M

$2,922,496

Total Sells (Filtered)

$0

$0

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
AKTX P Akari Therapeutics Plc Bazemore Robert B • Director Discretionary Buy 2025-12-16 $62,499x4 View Form 4 →
AKTX	Akari Therapeutics Plc	Bazemore Robert B Director Discretionary Buy	2025-12-16	$62,499x4	P	Form 4
AKTX P Akari Therapeutics Plc Farag Kameel D. • CFO Discretionary Buy 2025-12-16 $9,999x2 View Form 4 →
AKTX	Akari Therapeutics Plc	Farag Kameel D. CFO Discretionary Buy	2025-12-16	$9,999x2	P	Form 4
AKTX P Akari Therapeutics Plc Gaslightwala Abizer • CEO Discretionary Buy 2025-12-16 $437,499x4 View Form 4 →
AKTX	Akari Therapeutics Plc	Gaslightwala Abizer CEO Discretionary Buy	2025-12-16	$437,499x4	P	Form 4
AKTX P Akari Therapeutics Plc Huh Hoyoung • Director Discretionary Buy 2025-12-16 $1,499,999Largex4 View Form 4 →
AKTX	Akari Therapeutics Plc	Huh Hoyoung Director Discretionary Buy	2025-12-16	$1,499,999Largex4	P	Form 4
AKTX P Akari Therapeutics Plc Patel Samir Rashmikant • Director Discretionary Buy 2025-12-16 $343,750x4 View Form 4 →
AKTX	Akari Therapeutics Plc	Patel Samir Rashmikant Director Discretionary Buy	2025-12-16	$343,750x4	P	Form 4
AKTX P Akari Therapeutics Plc Patel Sandip I • Director Discretionary Buy 2025-12-16 $162,499x4 View Form 4 →
AKTX	Akari Therapeutics Plc	Patel Sandip I Director Discretionary Buy	2025-12-16	$162,499x4	P	Form 4
AKTX P Akari Therapeutics Plc Prudo-Chlebosz Raymond • Director Discretionary Buy 2025-12-16 $406,249x4 View Form 4 →
AKTX	Akari Therapeutics Plc	Prudo-Chlebosz Raymond Director Discretionary Buy	2025-12-16	$406,249x4	P	Form 4